Showing 7961-7970 of 8647 results for "".
- TECLens Donates 10,000 PPE Face Shields to Workers on Front Linehttps://modernod.com/news/teclens-donates-10000-ppe-face-shields-to-workers-on-front-line/2477543/TECLens announced the donation of 10,000 PPE face shields to the Montefiore Hospital System in Bronx, New York, for distribution to its hospitals’ frontline care givers. “Several weeks ago we established a dedicated network of 3D print makers to make face shield componen
- Mobius Therapeutics Continues Production and Distribution of Mitosolhttps://modernod.com/news/mobius-therapeutics-continues-production-and-distribution-of-mitosol/2477540/Mobius Therapeutics, the maker of Mitosol (mitomycin for solution) 0.2 mg/vial kit for ophthalmic use, has maintained production and inventory of Mitosol, recognizing the nonelective nature of the patient population affected by its intended use. Mitosol is the only FDA approved
- GlaxoSmithKline Takes $250 Million Stake in Vir as Companies Pair Up to Develop Coronavirus Treatmentshttps://modernod.com/news/glaxosmithkline-takes-250-million-stake-in-vir-as-companies-pair-up-to-develop-coronavirus-treatments/2477536/GlaxoSmithKline and Vir Biotechnology announced that they have agreed to enter into a collaboration to develop anti-viral antibodies for coronaviruses, including SARS-CoV-2. In addition, to gain access to Vir’s monoclonal antibody technology, GlaxoSmithKline said it will also make an equity
- Inovio Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Todayhttps://modernod.com/news/inovio-initiates-phase-1-clinical-trial-of-its-covid-19-vaccine-and-plans-first-dose-today/2477532/Inovio Pharmaceuticals announced that the FDA has accepted the company’s investigational new drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent COVID-19 infection, paving the way for phase 1 clinical testing of INO-4800 in healthy volunteers beginning this we
- EU Body Backs Compassionate Use of Gilead’s Remdesivir for COVID-19https://modernod.com/news/eu-body-backs-compassionate-use-of-gileads-remdesivir-for-covid-19/2479531/The European Medicines Agency (EMA) said its Committee for Medicinal Products for Human Use (CHMP) recommended compassionate use of Gilead Sciences’ investigational antiviral remdesivir to treat COVID-19. However, the agency cautioned that while remdesivir has been shown to be active agains
- Luxottica to Donate Hundreds of Thousands of Medical Masks, Outlines COVID-19 Safety and Relief Effortshttps://modernod.com/news/luxottica-to-donate-hundreds-of-thousands-of-medical-masks-outlines-covid-19-safety-and-relief-efforts/2477526/Responding to the COVID-19 pandemic, Luxottica Group has taken a number of steps, both in North America and Italy, to protect customers, employees, partners and medical workers, according to a VisionMonday
- Incyte, Novartis to Evaluate JAK Inhibitor Ruxolitinib for Severe COVID-19 Patientshttps://modernod.com/news/incyte-novartis-to-evaluate-jak-inhibitor-ruxolitinib-for-severe-covid-19-patients/2477527/Incyte and Novartis announced that the companies plan to initiate a phase 3 collaborative study to assess ruxolitinib plus standard-of-care, versus standard care alone, in patients suffering from COVID-19-associated cytokine storm. The clinical trial will be sponsored by Incyte in the US, where t
- CRST: Hydroxychloroquine for the Treatment and Prevention of COVID-19https://modernod.com/news/hydroxychloroquine-for-the-treatment-and-prevention-of-covid-19/2477524/A new article published online in Cataract & Refractive Surgery Today (CRST) provides an in-depth examination of the use of hydroxychloroquine for both prophylaxis a
- New Guidance Issued on Paycheck Protection Program Loanshttps://modernod.com/news/new-guidance-issued-on-ppp-loans/2477525/New guidance was posted to the Treasury website regarding the Paycheck Protection Program (PPP), which authorizes up to $349 billion toward job retention and certain other expenses for s
- 2020 World Ophthalmology Congress Cancelled; Virtual Program Plannedhttps://modernod.com/news/2020-world-ophthalmology-congress-cancelled-virtual-program-planned/2479534/Due to the COVID-19 pandemic, The International Council of Ophthalmology (ICO) has decided to cancel the World Ophthalmology Congress (WOC2020), scheduled to take place June 26-29, in Cape Town, Africa. In a message to its members, ICO leadership stated that it remains devoted to bringing